Allarity Therapeutics (ALLR) Institutional Ownership $1.04 +0.03 (+2.97%) Closing price 04:00 PM EasternExtended Trading$1.02 -0.02 (-1.44%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Allarity Therapeutics (NASDAQ:ALLR)CurrentInstitutional OwnershipPercentage11.53%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$78.73KNumber ofInstitutional Sellers(last 12 months)0 Get ALLR Insider Trade Alerts Want to know when executives and insiders are buying or selling Allarity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Allarity Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Stonepine Capital Management LLC67,289$79K0.1%N/A1.518% 11/15/2023Sabby Management LLC359,400$268K0.2%N/A13.165% 11/15/2023Armistice Capital LLC261,000$195K0.0%N/A9.560% (Data available from 1/1/2016 forward) ALLR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALLR shares? During the previous two years, the following institutional investors and hedge funds held shares of Allarity Therapeutics shares: Sabby Management LLC ($268K), and Armistice Capital LLC ($195K), Stonepine Capital Management LLC ($79K).Learn more on Allarity Therapeutics' institutional investors. What percentage of Allarity Therapeutics' stock is owned by institutional investors? 11.53% of Allarity Therapeutics' stock is owned by institutional investors. Learn more on ALLR's institutional investor holdings. Which institutional investors have been buying Allarity Therapeutics' stock? The following institutional investors have purchased Allarity Therapeutics' stock in the last 24 months: Sabby Management LLC ($359.40K), Armistice Capital LLC ($261K), and Stonepine Capital Management LLC ($67.29K). How much institutional buying is happening at Allarity Therapeutics? Institutional investors have bought a total of 67,289 shares in the last 24 months. This purchase volume represents approximately $78.73K in transactions. Related Companies Genenta Science Major Shareholders Senti Biosciences Major Shareholders Metagenomi Major Shareholders Verrica Pharmaceuticals Major Shareholders Kronos Bio Major Shareholders Werewolf Therapeutics Major Shareholders InflaRx Major Shareholders Precision BioSciences Major Shareholders Gain Therapeutics Major Shareholders Cue Biopharma Major Shareholders This page (NASDAQ:ALLR) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALLR Stock Alerts